Lyra Therapeutics (LYRA) Assets Average (2020 - 2025)
Quarterly Assets Average fell 44.99% to $39.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.9 million through Dec 2025, down 44.99% year-over-year, with the annual reading at $51.2 million for FY2025, 50.97% down from the prior year.
Lyra Therapeutics' Assets Average history spans 6 years, with the latest figure at $39.9 million for Q4 2025.
- Assets Average came in at $39.9 million for Q4 2025, down from $48.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $142.1 million in Q1 2024 to a low of $39.9 million in Q4 2025.
- The 5-year median for Assets Average is $81.8 million (2021), against an average of $87.7 million.
- Year-over-year, Assets Average surged 175.88% in 2021 and then plummeted 56.83% in 2025.
- Lyra Therapeutics' Assets Average stood at $61.3 million in 2021, then soared by 87.09% to $114.7 million in 2022, then rose by 14.71% to $131.6 million in 2023, then tumbled by 44.86% to $72.6 million in 2024, then tumbled by 44.99% to $39.9 million in 2025.
- Per Business Quant, the three most recent readings for LYRA's Assets Average are $39.9 million (Q4 2025), $48.1 million (Q3 2025), and $54.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 40.71 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 26.03 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Lyra Therapeutics | - | - | - | 39.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.91 Mn |
| Sep 30, 2025 | 48.14 Mn |
| Jun 30, 2025 | 54.44 Mn |
| Mar 31, 2025 | 61.33 Mn |
| Dec 31, 2024 | 72.55 Mn |
| Sep 30, 2024 | 86.67 Mn |
| Jun 30, 2024 | 118.05 Mn |
| Mar 31, 2024 | 142.06 Mn |
| Dec 31, 2023 | 131.59 Mn |
| Sep 30, 2023 | 123.13 Mn |
| Jun 30, 2023 | 109.77 Mn |
| Mar 31, 2023 | 101.92 Mn |
| Dec 31, 2022 | 114.72 Mn |
| Sep 30, 2022 | 124.75 Mn |
| Jun 30, 2022 | 88.69 Mn |
| Mar 31, 2022 | 51.11 Mn |
| Dec 31, 2021 | 61.31 Mn |
| Sep 30, 2021 | 72.05 Mn |
| Jun 30, 2021 | 74.62 Mn |
| Mar 31, 2021 | 76.87 Mn |
| Dec 31, 2020 | 84.08 Mn |
| Sep 30, 2020 | 90.03 Mn |
| Jun 30, 2020 | 66.74 Mn |
| Mar 31, 2020 | 27.86 Mn |